Browsing Centre for Biochemical Pharmacology by Author "Peters, M"
Now showing items 1-7 of 7
-
Comparative effectiveness of Anti-IL5 and Anti-IgE biologic classes in patients with severe asthma eligible for both
Pfeffer, PE; Ali, N; Murray, R; Ulrik., C; Tran, TN; Maspero, J; Peters, M; Christoff, GC; Sadatsafavi, M; Torres-Duque, CA (2023) -
Comparative effectiveness of Anti-IL5 and Anti-IgE biologic classes in severe asthma patients eligible for both
Price, D; pfeffer, P; Ali, N; Murray, R; Ulrik, C; Tran, T; Maspero, J; Peters, M; Christoff, G; Sadatsafavi, M (2022) -
Eosinophilic and non-eosinophilic asthma: an expert consensus framework to characterize phenotypes in a global real-life severe asthma cohort.
Heaney, LG; Perez de Llano, L; Al-Ahmad, M; Backer, V; Busby, J; Canonica, GW; Christoff, GC; Cosio, BG; FitzGerald, JM; Heffler, E (2021-04-19)BACKGROUND: Phenotypic characteristics of eosinophilic and non-eosinophilic asthma patients are not well-characterized in global, real life severe asthma cohorts. RESEARCH QUESTION: What is the prevalence of eosinophilic ... -
Exploring definitions and predictors of response to biologics for severe asthma.
Scelo, G; Tran, TN; Le, TT; Faregås, M; Dorscheid, D; Busby, J; Al-Ahmad, M; Al-Lehebi, R; Altraja, A; Beastall, A (Elsevier, 2024-05-19)BACKGROUND: Biologic effectiveness is often assessed as 'response', a term which eludes consistent definition. Identifying those most likely to respond in real-life has proven challenging. OBJECTIVE: To explore definitions ... -
Exploring Definitions and Predictors of Severe Asthma Clinical Remission Post-Biologic in Adults.
Perez-de-Llano, L; Scelo, G; Tran, TN; Le, TT; Faregås, M; Cosio, BG; Peters, M; Pfeffer, PE; Al-Ahmad, M; Al-Lehebi, RO (American Thoracic Society, 2024-05-03)RATIONALE: There is no consensus on criteria to include in an asthma remission definition in real-life. Factors associated with achieving remission post-biologic-initiation remain poorly understood. OBJECTIVES: To quantify ... -
Impact of Initiating Biologics in Patients With Severe Asthma on Long-Term Oral Corticosteroids or Frequent Rescue Steroids (GLITTER): Data From the International Severe Asthma Registry.
Chen, W; Tran, TN; Sadatsafavi, M; Murray, R; Wong, NCB; Ali, N; Ariti, C; Bulathsinhala, L; Gil, EG; FitzGerald, JM (2023-09)BACKGROUND: Effectiveness of biologics has neither been established in patients with high oral corticosteroid exposure (HOCS) nor been compared with effectiveness of continuing with HOCS alone. OBJECTIVE: To examine the ... -
International severe asthma registry (ISAR): protocol for a global registry
FitzGerald, JM; Tran, TN; Alacqua, M; Altraja, A; Backer, V; Bjermer, L; Bjornsdottir, U; Bourdin, A; Brusselle, G; Bulathsinhala, L (BioMed Central, 2020-08-14)